CST3 and prostate cancer: We further investigated whether cystatin C expression correlated with clinical outcome in prostate cancer patients, and we divided patients into two groups based on the level of cystatin C expression: cystatin C high (intensity of staining 2 or 3) or cystatin C low (intensity of staining less than 2) group.